- March 25, 2023
- Newsletter
- 617-430-5616
Menu
Brand Name :
Zingo, Xylocaine
Synonyms :
lidocaine anesthetic
Class :
Local Anesthetics, Dentals, Parentrals
Dosage Forms & Strengths
Injectable Solution
0.4%
0.5%
0.8%
1%
1.5%
2%
4%
5%
Peripheral Nerve Blocks
Dental: Administer 1 to 5ml of 2% solution (20 to 100mg of total dose)
Paravertebral- Administer 3 to 5ml of 1% solution (30 to 50mg of total dose)
Obstetrical paracervical analgesia- Administer 10 ml of 1% solution (100mg of total dose)
Brachial- Administer 15 to 20ml of 1.5% solution (225 to 300mg of total dose)
Intercostal-Administer 3ml of 1% solution (30 mg of total dose)
Pudendeal- Administer 10 ml of 1% solution (100mg of total dose)
Epidural/Central Nerve Blocks
Thoracic- Administer 20 to 30ml of 1% solution (200 to 300mg of total dose)
Lumbar Anesthesia- Administer 15 to 20ml of 1.5% solution (225 to 300mg of total dose) or 10 to 15ml of 2% solution (200 to 300mg of total dose)
General-Administer for anesthesia 2 to 3ml/dermatome
Lumbar Analgesia-Administer 25 to 30 ml of 1% solution (250 to 300mg of total dose)
Infiltration Anesthesia
Intravenous region: Administer 10 to 60 mL of 0.5% solution (50 to 300 mg of total dose)
Percutaneous: Administer 1 to 60 mL of 0.5-1% solution (5 to 300 mg of total dose)
Sympathetic Nerve Blocks
Lumbar: Administer 5 to 10 mL of 1% solution (50 to 100 mg total dose)
Cervical: Administer 5 mL of 1% solution (50 mg total dose)
Dosage Forms & Strengths
Injectable Solution
0.5%
1%
1.5%
2%
4%
5%
Indicated for Infiltration Anesthesia :
Intravenous region: Administer 3mg/kg
Percutaneous: Administer a maximum dose of 4 to 4.5mg/kg
Refer adult dosing
may increase the adverse effect of lidocaine
may increase the serum concentration of CYP3A4 Substrates
may increase the serum concentration of lidocaine when combined
may increase the serum concentration of lidocaine
may increase the serum concentration of lidocaine
may diminish the serum concentration of Lidocaine
may diminish the serum concentration of Lidocaine
may diminish the serum concentration of Lidocaine
may diminish the serum concentration of Lidocaine
may diminish the serum concentration of Lidocaine
may increase the serum concentration of Lidocaine
may increase the serum concentration of Lidocaine
may increase the serum concentration of Lidocaine
may increase the serum concentration of Lidocaine
may increase the serum concentration of Lidocaine
may diminish the serum concentration of lidocaine
may diminish the serum concentration of lidocaine
may diminish the serum concentration of lidocaine
may diminish the serum concentration of lidocaine
may diminish the serum concentration of lidocaine
may increase the adverse effect of Methemoglobinemia Associated Agents
may increase the adverse effect of Methemoglobinemia Associated Agents
may increase the adverse effect of Methemoglobinemia Associated Agents
may increase the adverse effect of Methemoglobinemia Associated Agents
may increase the adverse effect of Methemoglobinemia Associated Agents
may increase the adverse effect of Local Anesthetics
may increase the adverse effect of Local Anesthetics
may increase the adverse effect of Local Anesthetics
may increase the adverse effect of Local Anesthetics
may increase the adverse effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
Actions and Spectrum:
Frequency not defined
Bradycardia
Edema
Heart block
Agitation
Confusion
Dizziness
Euphoria
Arrhythmias
Cardiovascular collapse
Hypotension
Apprehension
Coma
Drowsiness
Disorientation
Lightheadedness
Paresthesia
Sensations of heat, cold, or numbness
Seizures
Tremulousness
Visual disturbances, including blurred or double vision
Urticaria
Difficulty swallowing
Vomiting
Dyspnea
Nervousness
Slurred speech
Tinnitus
Unconsciousness
Skin lesions
Anaphylactoid reactions
Nausea
Muscle twitching/ tremors
Respiratory depression/arrest
Psychosis
Administration Effects
intramuscular injection increases serum creatine kinase
pain at the intramuscular injection site
Contraindications/caution:
Contraindications:
Caution:
Pregnancy consideration: B
Lactation:
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
lidocaine is a local anesthetic that works by blocking voltage-gated sodium channels in the membranes of nerve cells. This action prevents the initiation and propagation of nerve impulses in a specific area of the body, leading to local anesthesia.
Pharmacodynamics:
Pharmacokinetics:
Absorption
lidocaine can be administered via various routes, including topical, transdermal, injectable, and oral routes. The absorption of lidocaine depends on the route of administration, with topical and transdermal formulations having slower and less predictable absorption than injectable formulations. Oral formulations of lidocaine have poor bioavailability due to extensive first-pass metabolism in the liver.
Distribution
After absorption, lidocaine is distributed throughout the body. lidocaine has a high affinity for binding to plasma proteins, particularly alpha-1 acid glycoprotein (AAG) and albumin. The volume of distribution of lidocaine can vary depending on the formulation and route of administration, with a volume of distribution of 0.7-2.7 L/kg for the patch formulation.
Metabolism
The cytochrome P450 enzyme system primarily metabolizes lidocaine in the liver, specifically the CYP3A4 and CYP1A2 isoforms. The primary metabolites of lidocaine are monoethylglycinexylidide (MEGX) and glycinexylidide (GX), less active than lidocaine. MEGX and GX are further metabolized by hydrolysis and excreted in the urine.
Elimination and Excretion
lidocaine and its metabolites are excreted primarily in the urine, with a small amount excreted in feces. The elimination half-life of lidocaine can vary depending on the dose and route of administration, with an initial half-life of 7-30 minutes and a terminal half-life of 1.5-2 hours. lidocaine clearance is affected by factors such as liver and kidney function, age, and co-administration of other medications.
Administration:
lidocaine can be administered via several routes, including topical, transdermal, injectable, and oral routes. The administration route of lidocaine depends on the intended use and the patient’s medical condition. Here is a brief overview of the administration of lidocaine for different purposes:
Patient information leaflet
Generic Name: lidocaine anesthetic
Why do we use lidocaine anesthetic
lidocaine is a local anesthetic that is widely used for various medical purposes. Here are some of the common uses of lidocaine: